Literature DB >> 10383350

Toward evidence-based medical statistics. 2: The Bayes factor.

S N Goodman1.   

Abstract

Bayesian inference is usually presented as a method for determining how scientific belief should be modified by data. Although Bayesian methodology has been one of the most active areas of statistical development in the past 20 years, medical researchers have been reluctant to embrace what they perceive as a subjective approach to data analysis. It is little understood that Bayesian methods have a data-based core, which can be used as a calculus of evidence. This core is the Bayes factor, which in its simplest form is also called a likelihood ratio. The minimum Bayes factor is objective and can be used in lieu of the P value as a measure of the evidential strength. Unlike P values, Bayes factors have a sound theoretical foundation and an interpretation that allows their use in both inference and decision making. Bayes factors show that P values greatly overstate the evidence against the null hypothesis. Most important, Bayes factors require the addition of background knowledge to be transformed into inferences--probabilities that a given conclusion is right or wrong. They make the distinction clear between experimental evidence and inferential conclusions while providing a framework in which to combine prior with current evidence.

Mesh:

Year:  1999        PMID: 10383350     DOI: 10.7326/0003-4819-130-12-199906150-00019

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  168 in total

Review 1.  Sifting the evidence-what's wrong with significance tests?

Authors:  J A Sterne; G Davey Smith
Journal:  BMJ       Date:  2001-01-27

2.  Bayesian communication: a clinically significant paradigm for electronic publication.

Authors:  H P Lehmann; S N Goodman
Journal:  J Am Med Inform Assoc       Date:  2000 May-Jun       Impact factor: 4.497

3.  Naturopathy, pseudoscience, and medicine: myths and fallacies vs truth.

Authors:  Kimball C Atwood
Journal:  MedGenMed       Date:  2004-03-25

4.  Assessing the probability that a positive report is false: an approach for molecular epidemiology studies.

Authors:  Sholom Wacholder; Stephen Chanock; Montserrat Garcia-Closas; Laure El Ghormli; Nathaniel Rothman
Journal:  J Natl Cancer Inst       Date:  2004-03-17       Impact factor: 13.506

5.  Commentary: Genome-wide significance thresholds via Bayes factors.

Authors:  Jon Wakefield
Journal:  Int J Epidemiol       Date:  2012-02-15       Impact factor: 7.196

6.  Bad statistical practice in pharmacology (and other basic biomedical disciplines): you probably don't know P.

Authors:  Michael J Lew
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

7.  Proteomic analysis of a rat pancreatic stellate cell line using liquid chromatography tandem mass spectrometry (LC-MS/MS).

Authors:  Joao A Paulo; Raul Urrutia; Peter A Banks; Darwin L Conwell; Hanno Steen
Journal:  J Proteomics       Date:  2011-09-25       Impact factor: 4.044

Review 8.  Improving the analysis of routine outcome measurement data: what a Bayesian approach can do for you.

Authors:  Rivka M de Vries; Rob R Meijer; Vincent van Bruggen; Richard D Morey
Journal:  Int J Methods Psychiatr Res       Date:  2015-10-08       Impact factor: 4.035

9.  Negative randomized clinical trials (RCTs): further insight from the biostatistician's point of view.

Authors:  Bruno Mario Cesana
Journal:  Intensive Care Med       Date:  2015-10-21       Impact factor: 17.440

10.  Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia.

Authors:  Alison Gardner; Gloria Mattiuzzi; Stefan Faderl; Gautam Borthakur; Guillermo Garcia-Manero; Sherry Pierce; Mark Brandt; Elihu Estey
Journal:  J Clin Oncol       Date:  2008-10-27       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.